VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,100,218 | -9.9% | 338,172 | +0.8% | 0.08% | -7.1% |
| Q2 2023 | $10,097,884 | -13.6% | 335,366 | -7.2% | 0.08% | -16.7% |
| Q1 2023 | $11,686,549 | -5.1% | 361,253 | -16.0% | 0.10% | -10.5% |
| Q4 2022 | $12,319,543 | +74.8% | 429,851 | +47.1% | 0.11% | -19.1% |
| Q3 2022 | $7,047,000 | +16.0% | 292,151 | +31.7% | 0.14% | +45.4% |
| Q2 2022 | $6,075,000 | -24.0% | 221,883 | +6.4% | 0.10% | -15.7% |
| Q1 2022 | $7,997,000 | -26.8% | 208,515 | -38.8% | 0.12% | -26.3% |
| Q4 2021 | $10,919,000 | +13.9% | 340,904 | +4.8% | 0.16% | +2.6% |
| Q3 2021 | $9,588,000 | -18.3% | 325,337 | -5.8% | 0.15% | -19.1% |
| Q2 2021 | $11,733,000 | +7.9% | 345,292 | +3.2% | 0.19% | -12.1% |
| Q1 2021 | $10,876,000 | -7.1% | 334,648 | +3.0% | 0.21% | -7.8% |
| Q4 2020 | $11,705,000 | +64.4% | 324,972 | +78.7% | 0.23% | -60.2% |
| Q3 2020 | $7,120,000 | -28.4% | 181,807 | -32.9% | 0.58% | -36.7% |
| Q2 2020 | $9,938,000 | +60.1% | 270,950 | +0.6% | 0.92% | +21.2% |
| Q1 2020 | $6,206,000 | -18.3% | 269,344 | +3.7% | 0.76% | -0.4% |
| Q4 2019 | $7,594,000 | +15.8% | 259,712 | +5.7% | 0.76% | -4.3% |
| Q3 2019 | $6,558,000 | +9.4% | 245,799 | +4.9% | 0.80% | +3.1% |
| Q2 2019 | $5,995,000 | +42.8% | 234,229 | +25.1% | 0.77% | +30.4% |
| Q1 2019 | $4,198,000 | +14.0% | 187,269 | +7.1% | 0.59% | -1.3% |
| Q4 2018 | $3,683,000 | +43.4% | 174,819 | +26.1% | 0.60% | +62.9% |
| Q3 2018 | $2,568,000 | +31.9% | 138,614 | +59.1% | 0.37% | +7.9% |
| Q2 2018 | $1,947,000 | +50.1% | 87,105 | +47.9% | 0.34% | +40.7% |
| Q1 2018 | $1,297,000 | +17.9% | 58,905 | +24.7% | 0.24% | +20.3% |
| Q4 2017 | $1,100,000 | +0.7% | 47,238 | -1.2% | 0.20% | -16.5% |
| Q3 2017 | $1,092,000 | +13.2% | 47,800 | +9.4% | 0.24% | +2.1% |
| Q2 2017 | $965,000 | +52.4% | 43,675 | +57.0% | 0.24% | +35.4% |
| Q1 2017 | $633,000 | +13.2% | 27,820 | +4.0% | 0.18% | -5.9% |
| Q4 2016 | $559,000 | +88.9% | 26,745 | +139.4% | 0.19% | +46.5% |
| Q3 2016 | $296,000 | -31.6% | 11,170 | -28.5% | 0.13% | -25.3% |
| Q2 2016 | $433,000 | – | 15,630 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |